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ABSTRACT
In order to mount high-affinity antibody responses, B cells internalise
specific antigens and process them into peptides loaded onto MHCII
for presentation to T helper cells (TH cells). While the biochemical
principles of antigen processing and MHCII loading have been well
dissected, how the endosomal vesicle system is wired to enable
these specific functions remains much less studied. Here, we
performed a systematic microscopy-based analysis of antigen
trafficking in B cells to reveal its route to the MHCII peptide-loading
compartment (MIIC). Surprisingly, we detected fast targeting of
internalised antigen into peripheral acidic compartments that
possessed the hallmarks of the MIIC and also showed degradative
capacity. In these vesicles, internalised antigen converged rapidly
with membrane-derived MHCII and partially overlapped with
cathepsin-S and H2-M, both required for peptide loading. These
early compartments appeared heterogenous and atypical as they
contained a mixture of both early and late endosomal markers,
indicating a specialized endosomal route. Together, our data suggest
that, in addition to in the previously reported perinuclear late
endosomal MIICs, antigen processing and peptide loading could
have already started in these specialized early peripheral acidic
vesicles (eMIIC) to support fast peptide–MHCII presentation.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
B lymphocytes (B cells) are an essential part of the adaptive immune
system, initiating antibody responses against a vast repertoire of
different antigens. The presentation of specific antigen-derived
peptides loaded onto the major histocompatibility complex (MHC)
class II (MHCII) is critical for the ability of B cells to mount a mature
antibody response, including class-switch recombination and affinity
maturation. In addition, the presentation of the peptide–MHCII
(pMHCII) complex on the B cell surface enables them to act as
antigen-presenting cells (APCs) to CD4+ T lymphocytes (T helper
cells, TH cells). T cell receptor (TCR)–pMHCII interaction provides a
second activation signal to the B cells and, reciprocally, pMHCII
presented on B cells stimulates cognate TH cells to orchestrate other
branches of the immune system and to generate CD4+ T cell memory
(Whitmire et al., 2009).
Presentation of different antigenic peptides on MHCII is a critical
driver of various adaptive immune responses. Other professional
APCs, such as dendritic cells (DCs) and macrophages, present
peptides from antigens taken up unspecifically by phagocytosis or
via receptor-mediated uptake by innate immune receptors, like
complement receptors or Fc receptors. B cells, however, ensure
efficient presentation of antigens of given specificity, as determined
by the B cell antigen receptor (BCR) (Aluvihare et al., 1997;
Unanue et al., 2016). Studies on pMHCII loading have largely
focused on DCs andmacrophages, leaving B cell antigen processing
and presentation less understood.
The MHCII peptide-loading compartment (MIIC), where antigen
is processed into peptides for loading onto MHCII molecules, is
characterized by its main hallmarks, antigen and MHCII. In addition,
the MIIC contains the key peptide loading chaperone H2-M and the
proteolytic enzyme cathepsin-S (CatS) (Adler et al., 2017). TheMIIC
has been well characterized by various biochemical fractionation
techniques. However, in these assays the information about the
heterogeneity, localisation and dynamics of the vesicles is typically
lost. Therefore, important questions remain about the coordination of
antigen processing and MHCII loading and presentation. How the
endosomal vesicle machinery of B cells is tuned to enable this highly
specific process and how efficient targeting of BCR-bound antigen
for processing is coordinated remain unknown. It has been suggested
that MIICs are multivesicular and typically contain the late endosome
(LE)/lysosome marker late antigen membrane protein 1 (LAMP1)
(Adler et al., 2017; Lankar et al., 2002; Unanue et al., 2016). Thus, a
picture has been outlined where the maturation of MIIC diverts at the
stage of multivesicular bodies (MVBs) before fusion with end-stage
lysosome. However, it is not understood how this process is
regulated. To help to decipher the molecular underpinnings of
antigen presentation, deeper knowledge on intracellular trafficking of
antigen is required.
In the past 10–15 years, developments in fluorescence microscopy
techniques, including improved fluorophores and fluorescent fusion
proteins, as well as more sensitive and higher resolution imaging
modalities, have significantly increased our general understanding of
intracellular vesicle traffic. Microscopy can provide information
about the dynamics and heterogeneity of different vesicle carriers that
are otherwise challenging to decipher with other techniques. TheReceived 30 June 2019; Accepted 20 November 2019
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classical or ubiquitous endolysosomal pathway is delineated as a
route from early endosomes (EEs) to the LE/MVB and, finally, to
lysosomes, with early and late recycling endosomes (REs) sending
cargo back to the cell surface. While this general view is relatively
well established, new studies continue to reveal dramatic complexity
within the endolysosomal system with numerous vesicle sub-
populations, transport proteins and vesicle markers, as well as
vesicle scission and fusion machineries (Chen et al., 2019; Delevoye
et al., 2019; Huotari and Helenius, 2011). A group of vital regulators
of vesicle trafficking are the small GTPases of the Rab protein family,
which are widely used to define different endolysosomal sub-
populations. This family contains more than 60 proteins in humans
performing either ubiquitous or specific functions in vesicle
trafficking (Wandinger-Ness and Zerial, 2014). The appreciation of
the role of the Rab proteins has been key in unravelling endosomal
network dynamics. However, different carriers vary not only in terms
of their Rab identity markers, but also in size, shape, membrane
morphology, subcellular localisation and acidity. In addition,
identification of different cell-type-specific variations of vesicular
transport systems and diverse specialised endolysosome-related
organelles, where the MIIC could be included (Delevoye et al.,
2019), pose an ongoing challenge for researchers.
In this work, we set up a systematic microscopy approach to follow
how antigen, after BCR-mediated internalisation, traffics to theMIIC.
In accordance with previous studies, we detected and quantified
gradual clustering of antigen vesicles towards the perinuclear region
in 30–60 min. However, immediately after internalisation, antigen
was already present in heterogenous vesicles that harboured a mixed
selection of both early and late endosomal markers. Interestingly,
these early compartments in the cell periphery possessed hallmarks
of the MIIC and showed degradative capacity. By specific
visualisation of membrane-derived MHCII molecules, we found
that in these early antigen compartments, MHCII originated largely
from the plasma membrane pool, possibly to support fast, first-wave
peptide presentation. This study provides the first in-depth imaging of
antigen processing pathway in B cells. We found remarkable
efficiency in joint targeting of antigen and membrane-derived
MHCII into these peripheral compartments with hallmarks of the
MIIC, which we name early MIIC (eMIIC). The results increase our
understanding of the endolysosomal machinery responsible for MIIC
formation and can facilitate future dissections of the regulation of
successful antigen presentation.
RESULTS
Antigen migrates into the perinuclear area by 30–60 min
after activation
To characterise antigen vesicle trafficking in B cells, we first analyse
the migration and clustering of antigen in a quantitative manner. We
used cultured A20 B cells expressing transgenic D1.3 IgM (A20
D1.3) and activated them with Alexa Fluor-labelled anti-IgM
antibodies (AF-αIgM) as surrogate antigen. The localisation of the
antigen vesicles was imaged in cells fixed at different time points
and stained for pericentriolar material 1 (PCM1) as a marker for the
microtubule-organising centre (MTOC) by spinning disc confocal
microscopy (SDCM). We found that, within 30–60 min, most cells
gathered antigen in a cluster that typically localised quite centrally in
the cell, in the vicinity of the MTOC (Fig. 1A), which is highly
consistent with the literature (Aluvihare et al., 1997; Siemasko et al.,
1998; Tsui et al., 2018; Vascotto et al., 2007a). The same
phenomenon was also detected in splenic primary B cells isolated
from an MD4 mouse strain, selected for their relatively high and
homogenous levels of IgM. Primary B cells, however, showed faster
kinetics, with most cells having already accumulated antigen in
central clusters in less than 30 min (Fig. 1B). To quantitatively
analyse antigen migration, we deconvolved the images to improve
the separation of small vesicles, and then quantified the total number
of vesicles per cell and their mean distance to the MTOC with
MATLAB-based 3D analysis (Fig. 1C). By showing a reduction in
the vesicle number over time, the analysis clearly demonstrated the
fusion, or clustering, of vesicles into bigger entities. At the same
time, the average distance to the MTOC decreased, depicting
migration of the vesicles closer to the MTOC over time (Fig. 1D,E).
Although the vesicle number diminished between 30 and 45 min,
the mean distance of the vesicles to the MTOC remained constant.
This suggested that the majority of the antigen had already been
trafficked to the perinuclear region in 30 min, but vesicle fusion
events and/or clustering continued at later time points (Fig. 1E). The
quantification revealed the overall kinetics of the antigen transition
from smaller peripheral vesicles into bigger vesicles or vesicle
clusters that accumulate close to the MTOC.
In order to gain insights into the morphological features of the
antigen vesicles, we activated the A20 D1.3 cells with a mixture of
AF-αIgM and 6-nm-colloidal gold-conjugated anti-IgM and used
transmission electron microscopy (TEM) to visualise antigen-
containing membrane structures. We found high heterogeneity in
the vesicle morphologies, including multivesicular structures, both
after 15 min of activation and after 75 min of activation (Fig. 1F;
Fig. S1). As MIICs have earlier been characterised as MVB-like
structures (Adler et al., 2017; Lankar et al., 2002; Unanue et al.,
2016; Vascotto et al., 2007b), the localisation of antigen into
multivesicular structures raised a question as to whether at 15 min
after activation, in the cell periphery, antigen processing could have
already started. At the 75 min time point, the perinuclear area was,
in addition to antigen vesicles, very dense in various other
membrane organelles, such as Golgi and mitochondria. Consistent
with the literature (Vascotto et al., 2007a), we typically found these
vesicle-dense areas at sites of nuclear invaginations (Fig. 1F).
Antigen colocalisation with early and late endosomal
Rab proteins
Mechanisms of endolysosomal trafficking in various cellular
systems are largely governed by the Rab family of small
GTPases, which are commonly used to define sub-populations of
vesicles with different functions. To reveal the endolysosomal
character of the vesicles transporting antigen, we designed a series
of co-localisation analyses with the following classical endosomal
markers: Rab5 for EEs, Rab7 and Rab9 for LEs and lysosomes, and
Rab11 for REs (note that in mammals, there are more than one
isoform of the each of these Rab proteins, e.g. Rab5a, Rab5b and
Rab5c for Rab5; however, the antibodies used in the
immunofluorescence analysis typically recognize several isoforms
of each particular Rab protein). As antigen-bound BCR is known to
form clusters at the cell membrane prior to endocytosis, we first
examined the proportion of the dot-like antigen features that was
internalised at the 10–20 min time points, and thus would be
expected to colocalise with vesicular markers. At these early time
points most vesicles still remain in the cell periphery and it is not
readily apparent if the antigen is internalised or just clustered at the
plasma membrane. To distinguish the internalised antigen from the
antigen still on the plasma membrane, we stimulated the cells with
biotinylated AF-αIgM and stained with fluorescent streptavidin
(Fig. S2A). We detected that in 10–20 min, ∼40–50% of the dotted
antigen features in the images represented internalised vesicles,
while the rest of the signal originates from antigen that still remains
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Fig. 1. Antigen vesicles traffic to a perinuclear compartment in the vicinity of the MTOC. (A) A20 D1.3 B cells were activated with Alexa Fluor-labelled
anti-IgM antibodies (AF-αIgM) (antigen, magenta) for 10 or 60 min and stained with anti-PCM-1 (to label the MTOC, cyan). Cells were imaged with 3D SDCM and
deconvolved. Upper panel, single confocal planes; lower panel, z-projections of 10 µm stacks of representative cells. Scale bar: 5 µm. (B) Primary MD4 B
cells were activated with AF-αIgM (antigen, magenta) for different time points and stained with anti-PCM-1 (MTOC, cyan) and imaged as in A. z-projections of the
whole stacks from representative cells are shown. Scale bar: 5 µm. (C) Schematic of the vesicle quantification using a MATLAB-based script. Number of antigen
vesicles in one cell (in magenta) and mean distance from all the vesicles to the MTOC (in cyan) is measured in a 3D image. Left, schematic representation;
right, example image from the script. (D) Quantification of data for experiment shown in A. 3D images from cells activated for 15 (pink) and 45 (blue) min were
analysed as in C. Upper axis, mean number of vesicles per cell; right axis, mean distance of the vesicles to MTOC per cell. The two time points were compared
using a density plot. (E) Comparison of samples prepared as in A, activated for 15, 30 and 45 min and analysed as in C and D. The dashed lines represent
the median of the cell population in the 15 min sample. ****P<0.0001; ns, not significant (Student’s t-test). Data for time points 15 and 45 min are for two
experiments (n>200 cells) and that for 30 min are for one experiment (n>100 cells). (F) A20 D1.3 cells were activated with anti-IgM conjugated to 6 nm
colloidal gold particles mixed with AF647-αIgM, for 15 and 75 min and imaged using TEM. PM, plasma membrane.
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at the cell surface. As expected, at later time points (60 min), the
majority of the antigen pool was detected inside the cells (Fig. S2B,
C). This was also highly consistent with a flow cytometric analysis
of antigen internalisation (Fig. S2D). Consistent with these results,
we also frequently found non-internalised antigen at the plasma
membrane in TEM samples after 15 min of activation (Fig. S1A).
To study the colocalisation of antigen and different vesicle
markers, we performed immunofluorescence analysis with SDCM.
We expected to see clearly higher colocalisation of antigen with
early endosomal Rab5 in the early time points, and with LE/MVB
markers at later time points. To our surprise, we did not detect major
differences between the markers. Instead, Rab5, Rab7, Rab9 and
Rab11 all showed prominent punctate pattern of vesicles very close
to the plasma membrane that partially overlapped with antigen and
were partially located just underneath the antigen signal (Fig. 2A,C;
Fig. S3A). As a negative control, we used Golgi-specific transport
protein Rab6 and, as expected, it showed no notable colocalisation
with antigen. We quantified the colocalisation using Manders’
overlap coefficient, split for the antigen channel (M2) (Manders
et al., 1993), using Huygens software with automated thresholding.
M2 measures the portion of antigen that overlaps with the signal
from different Rab proteins. The analysis supported that there was
already partial colocalisation of antigen with Rab5, Rab7, Rab9 and
Rab11 at early time points after activation (Fig. 2C).
At the 60 min time point, when most of the antigen was clustered
in the perinuclear region, we found enhanced colocalisation with the
LE/MVB markers Rab7 and Rab9, as expected (Fig. 2B; Fig. S3B).
Rab11, involved in slow recycling, also localised to the antigen
cluster, as well as the EE marker Rab5. The negative control, Rab6,
was found in the perinuclear region close to antigen but with very
limited overlap in signals. This suggested translocation of the
antigen close to the Golgi, supporting the above observed
localisation close to the MTOC (Fig. 1). The quantification
suggested significant overlap of antigen with all the studied Rab-
proteins except Rab6, with an increasing trend over time (Fig. 2C).
We also analysed the possible effect of antigen uptake in the
distribution of Rab proteins by comparing the intensity of different
Rab-positive compartments in the vicinity of the MTOC to the
intensity throughout the cell before or 10 and 45 min after activation
(Fig. S4A,B). The change in the distribution was most clear in the
case of Rab7, which concentrated significantly closer to the MTOC
at late time points after activation, accompanied by a decrease in the
number of Rab7-positive vesicles (Fig. S4C,D). However,
interestingly the distribution of Rab9 did not show any alteration,
indicating functional divergence between these two LE/MVB
markers. On the other hand, Rab5 and Rab11 showed rather
increased dispersion away from the MTOC after 10 min, which
could be explained by the activation of the endocytic and exocytic
machineries in the case of Rab5 and Rab11, respectively.
The majority of the vesicles were found very close to each other,
both at the early and late time points, in the vicinity of the plasma
membrane or in the perinuclear region, respectively, leading to
overestimation of the signal overlap. The antigen vesicles detected
by SDCM, after deconvolution and the analysis by MATLAB script
(as in Fig. 1), range between 200 nm and 1 µm in diameter, with a
large majority of vesicles falling in between 400 and 500 nm (data
not shown). Based on EM micrographs, the actual size of the
antigen-containing unilamellar vesicles was, however, found to be
≈120 nm and multilamellar vesicles ≈290 nm (Fig. 1F; Fig. S1A,C),
suggesting that the apparent vesicle sizes in fluorescence microscopy
are affected by the limited resolution in optical microscopy. Small
vesicles located close together are not resolved individually, but
appear as one or several larger vesicles. In order to improve the
resolution of our data and to better separate different vesicles, with a
method still suitable for relatively large sample numbers and
quantification, we employed super-resolution radial fluctuation
(SRRF), an imaging method based on post-processing analysis of
signal fluctuations (Gustafsson et al., 2016). Here, we analysed
samples activated for 10 or 45 min in order to resolve the nature of
the antigen vesicles in the perinuclear region. Super-resolution
SRRF images were obtained by taking 20–50 repetitive images of
the same field of view via SDCM and post-processing the data using
the SRRF plugin in ImageJ. In this way, we could improve the
separation of the vesicles significantly, and now detected more
distinct differences in the localisation of the Rab proteins with
respect to antigen, especially at later time points. At 45 min, Rab7
and Rab9 showed clear colocalisation with antigen, as expected for
their late endosomal nature, while Rab5 and Rab11 appeared more
scattered and only partially colocalised with antigen, often marking
vesicles or membrane domains adjacent to it (Fig. 2D; Fig. S5). We
analysed SRRF images for the Manders’ overlap coefficient (M2)
and detected a marked colocalisation of antigen signal with the LE
markers Rab7 and Rab9 at 45 min. We also detected overlap with
Rab11, and, to some extent, with Rab5. However, in 10 min, the
analysis showed close to equal colocalisation of Rab5, Rab7 and
Rab9, and a modest level of colocalisation with Rab11.
Colocalisation of antigen with Rab6 remained low, confirming the
specificity of the analysis (Fig. 2E). The presence of Rab11 in the
antigen vesicles could suggest fission and recycling to some extent
had already occurred at early time points, but with increasing
efficiency towards later time points.
All together, these results point towards a previously unnoticed
heterogeneity in the antigen-containing endosomes. Early association
of antigen with classical LE/MVBmarkers Rab7 and Rab9 raises the
possibility that antigen vesicles deviate from classical steps of EE to
LE conversion during their maturation into the MIIC.
Antigen trafficking involves atypical vesicles that share both
early and late endosomal character
To better define antigen transport vesicles, we asked how other typical
EE and LE markers, early endosome antigen 1 (EEA1) and LAMP1,
respectively, correlatedwith antigen at different timepoints.Consistent
with the data on different Rab proteins, we detected partial
colocalisation of antigen with both EEA1 and LAMP1 already at
early time points (Fig. 3A; Fig. S3C). The colocalisation becamemore
prominent as antigen trafficked to the perinuclear region (Fig. 3B; Fig.
S3D). Manders’ overlap coefficient also showed continuous, or
perhaps even increasing, overlap with antigen for both markers
(Fig. 3C). However, Pearson’s correlation coefficients for EEA1 and
LAMP1 crossed over time indicating that a significantly higher
proportion of LAMP1 compared to EEA1 colocalised with antigen at
later time points. This is consistent with a high proportion of EEA1
endosomes remaining in the cell periphery,while some coalesce in the
central cluster togetherwith antigen, as shownby theM2value.On the
other hand, an increasing proportion of LAMP1-positive vesicles
accumulated in the perinuclear region with antigen over time.
As a complementary approach, we again turned to SRRF super-
resolution analysis in order to achieve higher accuracy. We examined
the colocalisation of antigenwithEEA1 andLAMP1 at 10 and 45 min
after activation. SRRF analysis confirmed higher colocalisation of
antigen with EEA1 compared to LAMP1 in the early time points
(10 min), andvice versa after 45 min (Fig. 3D,E).Nevertheless, EEA1
colocalisation with antigen was also detected both in some remaining
peripheral vesicles and in the perinuclear antigen vesicle cluster,
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raising a possibility that EEA1 could also indeed localise to theMIIC.
Together, these data revealed surprising localisation of antigen with
not only early but also late endosomal carriers shortly after
internalisation. At later time points, when vesicles were close to the
MTOC, the preference for LE/MVB markers was notable, yet EE
markers were also found to overlap with antigen.
Fig. 2. See next page for legend.
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As shown above (Fig. S2B,C), in 15 min approximately half of
the dots with antigen signal should represent vesicles inside the cell,
and the rest should originate from antigen–BCR clusters still at the
plasma membrane. Therefore, M2 values for one type of vesicle
marker should not be considerably higher than 50% at the early time
points. Our observation that antigen showed an overlap of 40–60%
with both early and late endosomal markers could simply reflect
technical challenges to resolve small vesicles close to each other,
causing adjacent vesicles to appear as colocalised. Additionally, it
could point towards mixed vesicle identities that would
simultaneously possess both types of markers. To test for these
two non-exclusive scenarios, we next performed SRRF super-
resolution analysis on cells activated either for 10 or 45 min and
stained for LAMP1 and EEA1, and asked if they colocalised in the
same antigen vesicles. We found vesicles, where antigen only
colocalised with either EEA1 or LAMP1, but we also found several
prominent vesicles that clearly contained both markers
simultaneously (Fig. 3G). To investigate whether this atypical
colocalisation was triggered by antigen uptake, we next analysed
non-activated cells. Interestingly, we found vesicles with clear
EEA1 and LAMP1 colocalisation even in resting cells. The
Pearson’s coefficient quantification showed lower colocalisation
in resting cells as compared to cells activated for 10 min, but
comparable colocalisation as in the cells activated for 45 min
(Fig. 3F; Fig. S6A). In order to seek for further confirmation for
these findings, we also analysed the colocalisation between other
pairs of early and late endosomal markers, namely Rab5 and
LAMP1, Rab7 and EEA1, and Rab9 and EEA1, before and after
activation. In all cases, at the resting state, we can already detect
some vesicles with colocalisation, but with very low overall level of
correlation, which again, however, increased by 10 min after
antigen stimulation (Fig. S6B).
Next, we asked whether the vesicles that share both early and late
endosomal markers were in the transition state of their maturation or
if they represented a special compartment. To investigate this, we
performed live imaging of A20 D1.3 B cells transfected with
green fluorescent protein (GFP)-fused Rab5a and loaded with
LysoTracker, a fluorescent tracer that labels low pH compartments,
such as the LE/MVBs and lysosomes. We followed antigen vesicles
at early time points after internalisation by SDCM. We detected
several antigen vesicles that contained both Rab5 and LysoTracker
(Fig. 3H;Movie 1). Joint movement of the markers implied physical
colocalisation, and indicated that antigen, indeed, traffics in atypical
vesicles that share both early and late endosomal features.
Interestingly, we also detected double-positive vesicles before cell
activation (Fig. S6C).
Antigen enters degradative compartments shortly after
internalisation
As the primary purpose of antigen uptake by B cells is to degrade it
for loading the resulting peptides onto MHCII complexes, we next
asked the question of where and when does the antigen degradation
start. We linked a fluorescent probe for proteolysis, DQ–ovalbumin
(DQ-Ova), to anti-IgM or specific HEL antigen recognised by the
D1.3 BCR (Fig. 4A). Fluorescent DQ moieties quench each other
when the probe remains intact. However, upon proteolysis the
quenching ceases and the fluorescence can be detected. We first
analysed the increase in DQ fluorescence by flow cytometry. We
could already detect a clear signal at 15–20 min that constantly
increased throughout the 45-min the analysis period, suggesting that
the proteolysis starts relatively soon after antigen uptake (Fig. 4B).
We detected a brighter DQ-Ova signal at later time points when it
was linked to HEL, despite this having similar internalisation rate to
anti-IgM (see Fig. S2D). Owing to the brighter signal of DQ-Ova
conjugated to HEL, we performed the microscopy analysis using
this probe. Fluorescence signal from antigen-linked DQ moieties
was also visible by microscopy at 20 min after activation. The DQ-
signal overlapped well with EEA1 and was also found to colocalise
with CatS, an enzyme essential for preparing the MHCII for peptide
loading (Fig. 4C).
To investigate the level of antigen colocalisation with CatS in a
more comprehensive way, we performed immunofluorescence
analysis in cells activated for 10 or 45 min. Conventional SDCM
imaging suggested partial colocalisation of CatS with antigen both
at the 10 and 45 min time points (Fig. 4D, upper panel). In order to
resolve the vesicles better, we performed SRRF analysis, and could
more unambiguously detect antigen vesicles that clearly contained
CatS by 10 min after activation (Fig. 4D, middle panel).
Interestingly, the colocalisation level remained roughly similar,
although low, at the later time points in the perinuclear region
(Fig. 4D, bottom panel; Fig. S6D).
Proteolytic activity typically requires that the vesicles have an
acidic pH. To examine the pH of the antigen-containing vesicles,
we used live imaging with LysoTracker, as its accumulation is
based on acidic pH. In line with our data above (Fig. 3H), we
already found strong colocalisation of antigen with LysoTracker at
the very early time points (1–5 min after activation) (Fig. 4E;
Movie 2). Notably, we also detected antigen fusing with
LysoTracker-positive vesicles immediately after internalisation,
indicating very fast and efficient targeting of antigen to acidic
vesicles (Fig. 4F; Movie 3). Curiously, LysoTracker-positive
vesicles appeared to ‘hover’ beneath the plasma membrane ready
to catch the internalised antigen.
In addition to LysoTracker, we indirectly studied vesicle pH by
analysing the fluorescent decay of FITC coupled to anti-IgM. While
Alexa Fluor fluorophores are highly stable at acidic pH, FITC
fluorescence is pH-sensitive. A20 D1.3 cells were activated using
both AF647-conjugated anti-IgM, as a control, and FITC-
conjugated anti-IgM as pH probe, and fluorescence intensities
were followed over time by flow cytometry. In agreement with our
results using DQ-Ova and fast colocalisation with Lysotracker-
positive compartments, we observed a decay in FITC signal already
at 5 min after internalisation that continued to further decrease
Fig. 2. Colocalisation analysis of antigen with different Rab proteins.
(A,B) SDCM imaging of A20 D1.3 cells activated with AF647-αIgM (antigen,
magenta) for 10 min (A) or 60 min (B) and immunostained for different Rab
proteins (Rab5, Rab7, Rab9, Rab11 and Rab6; cyan). Single confocal planes
from deconvolved images of representative cells are shown, and examples of
colocalising vesicles are indicated with yellow arrowheads. For clear
representation, single confocal planes close to the bottom of the cell are
shown for Rab5, Rab7, Rab9 and Rab11. For Rab6, a confocal plane from the
middle of the cell, where Golgi is typically located, was selected. See Fig. S3A,
B for z-projections. Scale bar: 5 µm. (C) Quantification of the data for
experiments as in A and B with additional time points. Antigen (Ag)
colocalisation with different Rab proteins was measured from deconvolved
images, analysing Manders’ overlap coefficients using Huygens. Data from
three independent experiments (>80 cells/time point) are shown as mean±
s.e.m. (D) Samples were prepared with cells activated for 10 or 45 min as in A,
B and imaged with iterative imaging of a single plane with SDCM (20–25
frames/plane) and post-processed to obtain SRRF super-resolution image
(antigen, magenta; Rabs, cyan). Examples of colocalising vesicles are
indicated with yellow arrowheads. Scale bars: 5 µm. (E) Quantification of the
SRRF data for experiments in D, analysing Manders’ overlap coefficients with
ImageJ. Data shown as mean±s.e.m. Data for the 45 min time point is for two
independent experiments and that for 10 min for one experiment (>25 cells/
time point).
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through the experiment (Fig. S6E). In contrast, the AF647 signal
remained constant, indicating high stability of the fluorophore.
Antigen colocalises with plasma membrane-derived MHCII
rapidly after internalisation
The data above suggests that antigen processing could be initiated in
the peripheral antigen vesicles shortly after internalisation. To
determine if these early vesicles might represent the MIIC, we asked
whether they also contain MHCII. We activated the cells for 10 or
60 min with fluorescent antigen and performed immunofluorescence
staining of total MHCII. As expected, we found MHCII to strongly
colocalise with antigen in the perinuclear antigen cluster at the
30 min time point. Interestingly, after 10 min of activation, we also
detected MHCII in various intracellular vesicles including those
containing antigen (Fig. S6F). Owing to the high signal originating
from the plasma membrane-resident MHCII and several internal
Fig. 3. See next page for legend.
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MHCII-positive structures, we decided to analyse the samples with
the super-resolution technique structured illumination microscopy
(SIM). SIM significantly improved the resolution and clarity of the
imaging (x-y-z), and we could detect strong colocalisation of antigen
and MHCII in clearly defined vesicles by 15 min after cell
activation. We detected extremely high M1 Manders’ overlap
coefficients in the areas with peripheral antigen vesicles, indicating
that almost all internalised antigen overlapped with MHCII. A
significant proportion of MHCII was also found with antigen in
these regions, as further supported by Pearson’s correlation
coefficient analysis (Fig. 5A).
To investigate whether the MHCII in the early antigen vesicles
was newly synthesised from the trans-Golgi network, or originated
from the plasmamembrane pool, we pre-labelled the surfaceMHCII
prior to cell activation (Fig. 5B). Interestingly, we saw a strong
localisation of surface-derived MHCII (sMHCII) to early antigen
vesicles (Fig. 5C). We then proceeded to verify the colocalisation by
performing live imaging of cells labelled with fluorescent anti-
MHCII antibody prior to activation with fluorescent antigen. The
movies revealed very high level of sMHCII in the antigen vesicles
(Fig. 5D; Movie 4). Finally, to further prove that the early antigen
vesicles could function as theMIIC, we stained the cells for H2-M, a
molecule of MHC family that functions as a key chaperone in
peptide loading to MHCII (Mellins and Stern, 2014). Notably,
SRRF super-resolution imaging of immunofluorescence samples
revealed that there already was clear colocalisation of antigen
vesicles and H2-M at 15 min after activation further supporting
classification of these vesicles as eMIICs (Fig. 5E; Fig. S6D).
Finally, to examine the functionality of eMIICs in peptide loading,
we utilised a well-stablished 3,3′ diaminobenzidine-peroxidase
(DAB-HRP) endosome ablation technique combined with an
ELISA-based antigen presentation assay. Monomeric DAB is
polymerised in the presence of H2O2 and HRP, selectively fixing
the HRP-containing endosomes by crosslinking the luminal and
membrane integral proteins of the vesicles (Henry and Sheff, 2008;
Pond andWatts, 1999; Stoorvogel et al., 1996). We pulsed A20 D1.3
cells with HRP-labelled anti-IgM antibody (HRP-αIgM) for 10, 20 or
45 min followed by DAB ablation of the HRP-αIgM-containing
endosomal compartments. Then, we activated the endosome-ablated
A20D1.3 cells with HEL antigen. By using a cognate T cell line, 1E5,
that recognises HEL-derived peptides on I-Ad, the particular type of
MHCII expressed by the A20 D1.3 B cells, we were able to measure
IL-2 secretion by T cells as an antigen presentation readout. We found
normal levels of peptide presentation when HRP-αIgM vesicles were
ablated after 10 min, and close to normal levels after 20 min
activation. At these time points, however, only a fraction of the
antigen is internalised (Fig. S2D), and the cells continue internalising
antigen and are likely to have remaining endosomal capacity for
trafficking. This indicates that, even if all HRP-αIgM endosomes are
ablated at these time points, a pool of early carriers still remains
functional. Interestingly, we also detected robust presentation, at 60%
compared to the non-treated cells, in cells where HRP-αIgM vesicles
were ablated after 40 min. At this time point, most of the antigen has
been internalised and reached the perinuclear MIICs (see Fig. 1 and
Fig. S2D). This result suggests that the perinuclear MIICs are not
fundamentally required for presentation but the eMIIC could also
generate pMHCII to support pMHCII generation. Nevertheless, it is
also possible that the DAB-HRP reaction does not completely abolish
all perinuclear MIICs, or that they are regenerated during the second
activation maturing from a non-ablated endosomal pool.
DISCUSSION
To the study vesicular networks responsible for antigen processing
in B cells, we utilised high and super-resolution microscopy for
systematic colocalisation analysis of antigen with key markers of
various endolysosomal compartments and known components of
MIIC. Consistent with previous studies (Aluvihare et al., 1997;
Siemasko et al., 1998; Vascotto et al., 2007a), we observed that,
over time, antigen concentrates in the perinuclear region together
with the LE/MBV markers LAMP1, Rab7 and Rab9, in
compartments closely fitting the description of the MIIC.
However, we also observed fast and highly efficient targeting of
antigen into acidic compartments that also possessed key features of
MIIC by minutes after internalisation. These vesicles, located in the
cell periphery, displayed a heterogenous combination of early and
late endosomal markers and also exhibited variable ultrastructural
morphologies. Interestingly, we show robust recruitment of surface-
derived MHCII to these compartments, which we named eMIICs,
suggesting that they could support fast presentation using MHCII
recycled from the plasma membrane (Fig. 6). This work provides
the first endosomal roadmap of the intracellular trafficking of
antigen in B cells and reveals previously unappreciated efficacy in
MIIC formation.
Much of our knowledge on B cell antigen processing
compartments is derived from biochemical studies, including cell
fractionations, radiolabelling of antigen and electron microscopy
(Amigorena et al., 1994; Lankar et al., 2002; West et al., 1994).
While these early studies had already drawn a valid picture of late
endosomal or lysosomal (i.e. LAMP1-positive), and multivesicular
compartment, the approaches were not suitable to address questions
about intracellular localisation or dynamics of the antigen vesicles.
However, these features have been strongly linked to distinct
functional properties of endolysosomes and they also inform us
about the possible molecular machineries regulating vesicle
trafficking (Huotari and Helenius, 2011; Hutagalung and Novick,
Fig. 3. Antigen colocalises with both EEA1 and LAMP1while trafficking to
the perinuclear region. (A,B) SDCM imaging of A20 D1.3 cells activated with
AF647-αIgM (antigen, magenta) for 10 min (A) or 60 min (B) and
immunostained for EEA1 or LAMP1 (cyan). Single confocal planes from
deconvolved images; representative cells are shown and examples of
colocalising vesicles are indicated with yellow arrowheads. See Fig. S3C,D for
z-projections. Scale bars: 5 µm. (C) Quantification of the data for experiments
as in A and Bwith additional time points. Antigen (Ag) colocalisation with EEA1
and LAMP1 was measured from deconvolved images, analysing Manders’
overlap coefficients and Pearson’s correlation coefficients using Huygens.
Data are from two independent experiments (>40 cells/time point) and are
shown as mean±s.e.m. (D) Samples were prepared with cells activated for 10
or 45 min as in A and B and imaged with iterative imaging of a single plane with
SDCM (20–25 frames/plane) and post-processed to obtain SRRF super-
resolution images (antigen, magenta; EEA1 or LAMP1, cyan). Examples of
colocalising vesicles are indicated with yellow arrowheads. Scale bar: 5 µm.
(E) Quantification of the SRRF data for experiments in D analysing Manders’
overlap coefficients with ImageJ. Data from three independent experiments
(>30 cells/time point) are shown as mean±s.e.m. (F) Quantification of EEA1
and LAMP1 colocalisation, analysing Pearson’s correlation coefficient with
Huygens. Data are from three independent experiments (>30 cells/time point)
shown as mean±s.e.m. *P<0.05, **P<0.01, ****P<0.0001 (Student’s t-test).
(G) Surface reconstruction, from the Huygens rendering tool, of SRRF images
from samples prepared as in D (antigen, magenta) and immunostained for
EEA1 (cyan) and LAMP1 (yellow). Three selected example vesicles are
highlighted in the magnification (zoom). (H) A20 D1.3 cells were transfected
with GFP–Rab5 (yellow), loaded with LysoTracker (cyan) and activated with
RRx–αIgM (antigen, magenta). Live imaging was performed with SDCM
(ORCA camera) on a single plane. On the left, a merge image of a
representative cell after 10 min of activation is shown. On the right, the region in
the white square is followed in each channel as a time-lapse for 12 s, starting
10 min after activation. See Movie 1.
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2011). Our microscopy analysis revealed a remarkable
heterogeneity in the endolysosomal markers of antigen vesicles
(Figs 1–3). However, the overlapping fluorescent signals could have
been derived from a vesicle containing two markers, two vesicles
containing different markers, or a multilobular vesicle with distinct
markers in different domains, and these distinct conditions cannot
be resolved by conventional light microscopy. Therefore, the small
size and crowdedness of the vesicles generated challenges for the
colocalisation analyses, particularly affecting the calculation of the
Manders’ overlap coefficient, which relies on area overlap. We
could, at least partially, overcome this limitation by performing
super-resolution SRRF and SIM analyses. While SDCM can
Fig. 4. Internalised antigen incorporates into vesicles with low pH and capability to degrade cargo. (A) Schematic view of the DQ-Ova–antigen (HEL)
sandwich used to probe proteolysis of antigen internalised by the BCR. (B) DQ-Ova and DQ-Ova–antigen (αIgM or HEL) degradation as assessed by flow
cytometry. Cells were labelled as in A, washed, and incubated for different times at 37°C, and the fluorescence of DQ-OVAwas acquired immediately. Results are
shown as fold increase (mean±s.d. of the DQ-OVA intensity, normalised to the intensity at time zero). n>2 independent experiments. (C) A20 D1.3 cells activated
with DQ-Ova–HEL (magenta) as in B, for 20 min, were immunostained for EEA1 or CatS (cyan). Images were acquired using SDCMwith the EVOLVE (EMCCD)
camera. z-projections of representative cells (n=3 independent experiments) are shown with examples of colocalising vesicles indicated with yellow arrowheads.
Scale bar: 5 µm. (D) A20 D1.3 cells activated with AF647-αIgM (antigen, magenta) for 10 or 45 min and immunostained for CatS (cyan) were imaged with
conventional SDCM (upper panel, single plane) or with iterative imaging to obtain SRRF super-resolution images (20–25 frames/plane) (middle and bottom
panels). Examples of colocalising vesicles are indicated with yellow arrowheads. Scale bar: 5 µm. (E,F) A20 D1.3 cells were loaded with LysoTracker (cyan) and
activated with AF488 F(ab′)2-αIgM (antigen, magenta). Live imaging was performed with SDCMwith the EVOLVE (EMCCD) camera every 2 s (E) or 500 ms (F),
starting as soon as possible after transition of the cells to 37°C under the microscope. (E) A time-lapse from a representative cell is shown and examples of
colocalising vesicles are indicated with yellow arrowheads. Scale bar: 5 µm. See Movie 2. (F) A time-lapse of an example movie highlighting a probable fusion
event between an internalising antigen (Ag) vesicle and a LysoTracker (LT)-stained vesicle (dashed yellow circle). Awhite square in themerge image (left) depicts
the region shown for the single channels in the right-hand panels. See Movie 3.
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achieve a lateral resolution of 250–300 nm, SIM and SRRF improve
the x-y resolution by∼2-fold. SIM also improves the axial resolution
by 2-fold from ∼600 to ∼300 nm.
The vesicle heterogeneity could be linked to the notion that
antigen enters vesicles with low pH (indicated by LysoTracker and
fast decay of FITC fluorescence) and degradative capacity
(demonstrated by DQ-Ova signal and partial overlap with CatS)
extremely fast after internalisation (Fig. 4). It has also been shown
that the amounts of Rab-proteins on a given vesicle can fluctuate,
increasing the noise in the colocalisation parameters (Huotari and
Fig. 5. See next page for legend.
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Helenius, 2011; Hutagalung and Novick, 2011; Rink et al., 2005;
Vonderheit and Helenius, 2005). Notably, we found that antigen
also trafficked in atypical vesicles stably marked by both early
endosomal Rab5 and LysoTracker indicating that the heterogeneity
of the vesicles would be a more constant feature and not a mere
transition state. Our data do not clearly fit the classical ‘Rab
conversion’ model, where a vesicle rapidly shifts from being Rab5
positive into being Rab7 positive (Huotari and Helenius, 2011;
Hutagalung and Novick, 2011). Instead, the data might better
comply with an alternative model, where sequential budding of
membrane domains with LE markers would occur from EE/sorting
endosomes (Huotari and Helenius, 2011; Wandinger-Ness and
Zerial, 2014) and, indeed, we often detected adjacent localisation of
different markers possibly indicative of distinct domain on the same
vesicle.
Martinez–Martin and colleagues used SIM to demonstrate, in
primary B cells, that 15 min after activation, part of the internalised
antigen concentrated in ring-like structures representing
autophagosomes (Martinez-Martin et al., 2017). However, it
remains unclear what could be the role of autophagy in terms of
antigen fate or pMHCII processing. In our SIM analysis, we also
detected some ring-like structures, which could represent
autophagosomes (Fig. 5A) and the partial partitioning of antigen in
these autophagosomes, or amphisomes, could explain some of the
vesicle heterogeneity we observed. Our data also does not rule out
contribution of other vesicular carriers, like clathrin-independent
carriers (CLICs), void of specific markers (Kirkham et al., 2005).
An interesting finding from our live imaging data was that the
LysoTracker-positive (i.e. low pH) vesicles, appeared to ‘hover’ close
to the plasma membrane and capture antigen right after internalisation
(Fig. 4F). Some of these LysoTracker-positive vesicles also already
contained Rab5 before cell activation (Fig. S6C). The overexpression
of Rab proteins has some caveats and Rab5–GFP can, for instance,
lead to the generation of enlarged EEs and only partially recapitulate
the behaviour of endogenous Rab5.We, however, also stained B cells
for different pairs of endogenous early and late endosomal markers,
and consistently found indications of colocalisation of both markers,
especially in early stages after cell activation but to some extent
already prior to cell activation (Fig. 3F; Fig. S6). This effectiveness
suggests prewiring of the B cells endolysosomal system towards
antigen presentation, accompanied or boosted by a signalling
component from the BCR, as indicated by our analysis in steady-
state versus activated cells (Fig. S6) and as suggested previously by
Siemasko and colleagues (Siemasko et al., 1998). As such, we
support MIIC to be considered as a member of the growing family of
specialised endolysosome-related organelles (ELRO) with diverse
functions, as proposed in a recent review by Delevoye and colleagues
(Delevoye et al., 2019). Considering the poor compliance of antigen
vesicles with classical endolysosomal pathway, other ELROs could
serve as valuable additional points of comparisons for studies ofMIIC
membrane trafficking. It has been shown that B cells on activatory
surfaces mimicking immunological synapses, polarise theMTOC and
acidicMHCII vesicles leading to the secretion of proteases for antigen
extraction (Yuseff et al., 2011). While this happens at later stages of
activation and is proposed to precede antigen internalisation, it
demonstrates atypical functions of B cell acidic compartments,
perhaps analogous to the secretion of lytic granules, another type of
ELRO, by CD8+ T cells (Delevoye et al., 2019; Yuseff et al., 2013).
Early biochemical studies, using lipopolysaccharide-activated B
lymphoblasts, have proposed the existence of peptide-loaded
MHCII in multiple endolysosomal compartments (Castellino and
Germain, 1995) and, using the same B cell line as us, demonstrated
that B cells can indeed already present antigen at 20 min after
activation (Aluvihare et al., 1997). Furthermore, studies have shown
antigen degradation into peptides 20 min after activation (Barroso
et al., 2015; Davidson et al., 1990). These studies are consistent with
our finding that the internalised antigen vesicles highly efficiently
colocalise with MHCII in various compartments, as well as partially
overlap with CatS and H2-M (Figs 4 and 5). The acidic nature and
degradative capacity of the eMIICs (Figs 4 and 5) further supports
the idea that these compartments have a function in antigen
processing, which is also suggested by robust pMHCII presentation
detected in the cells where late perinuclear MIICs were ablated with
a DAB-HRP reaction (Fig. 5F).
Interestingly, we found that the newly internalised antigen
robustly colocalised with surface-derived MHCII (Fig. 5),
suggesting that the pre-existing pool of MHCII could be used for
the first wave of pMHCII presentation. This point has been
previously tested using cycloheximide, known to block de novo
protein synthesis. There, however, cycloheximide was found to
inhibit all presentation and it was interpreted that B cells could only
present peptides on newly synthesised MHCII (Aluvihare et al.,
1997). Later, concerns have been raised on the side effects of
cycloheximide. These include disturbance of vesicle trafficking,
actin cytoskeletal dynamics and cell polarisation and motility
(Clotworthy and Traynor, 2006; Darvishi and Woldemichael, 2016;
Oksvold et al., 2012). Thus, the early findings with cycloheximide
warrant revisiting with a sensitive pulse assay for antigen
presentation together with more specific inhibitors like, for
Fig. 5. Antigen and surface-derived MHCII rapidly converge after
internalisation. (A) SIM imaging of A20 D1.3 cells activated with AF647-αIgM
(antigen, magenta) for 15 min and immunostained for MHC-II (cyan).
A representative cell (stack image with 0.125 µm step size) is shown on the left
with white squares indicating the regions shown as I–IV (1.6 µm×1.6 µm) on
the right. Quantification of each region is shown below as: M1 (Manders’
coefficient 1; percentage colocalisation of antigen with MHCII), M2 (Manders’
coefficient 2; percentage colocalisation of MHCII with antigen) and R
(Pearson’s correlation coefficient). Scale bar: 5 µm. (B) A schematic view on
the staining to distinguish surface-derived MHCII from the total pool, used in C
and D. (C) A20 D1.3 cells (plane image; antigen in magenta) were stained with
anti-MHCII (AF488) before activation with RRx-αIgM (antigen, magenta) to
label surface-bound MHCII (sMHCII, cyan). After activation for 10 or 45 min at
37°C, cells were fixed and permeabilised and stained with anti-MHCII and a
secondary antibody (AF633; tMHCII, yellow). Samples were imaged with
iterative imaging of a single plane with SDCM (20–25 frames/plane) and post-
processed to obtain SRRF super-resolution images. Upper panel:
representative cell; lower panel, magnification of the region shown by the
coloured square in the upper panel. Examples of colocalising vesicles are
indicated with yellow arrowheads. Scale bar: 5 µm. (D) Live imaging of
A20D1.3 stained on icewith AF488-anti-MHCII (cyan) and RRx-αIgM (antigen,
magenta). Samples were imaged every 5 s using SDCM after 1 min at 37°C
(ORCA camera). A time-lapse from a representative cell is shown, and
examples of colocalising vesicles are indicated with yellow arrowheads. Scale
bar: 5 µm. See Movie 4. (E) SRRF imaging of A20 D1.3 cells activated with
AF647-αIgM (antigen, magenta) for 10 or 45 min and immunostained for H2-M
(cyan). A representative cell is shown and examples of colocalising vesicles
are indicated with yellow arrowheads. Scale bar: 5 µm. (F) A schematic
illustration explaining the experimental process of DAB-mediated endosome
ablation and antigen presentation to T cells. (G) Effect of DAB-mediated
endosome ablation on antigen presentation measured as IL-2 secretion by
ELISA, as schematically illustrated in F. HEL (−): negative control, untreated
A20 D1.3 cells without antigen. HEL (+): positive control, untreated cells
activated with HEL. DAB: cells treated with DAB and HRP (without H2O2) and
activated with HEL. DAB/H2O2: cells treated with DAB andH2O2 (without HRP)
and activated with HEL. anti-IgM-HRP: cells activated with HRP-αIgM for
different time points, treated with DAB and H2O2 and activated with HEL.
Results are mean±s.d. (n=3) and are shown as percentage of IL-2 secretion
compared to that in the control cells [HEL(+), set at 100%].
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example, the newly developed FLI-06 that targets ER exit sites and
the trans-Golgi network (Yonemura et al., 2016). Our suggestion
that biosynthetic MHCII probably arrives to MIIC at later stages, is
supported by the early metabolic labelling studies, where, again
using the same B cell line as that in our study, it was shown that the
newly synthesised MHCII arrives to MIIC in 30–60 min after cell
activation (Amigorena et al., 1994).
eMIICs could facilitate the speed of pMHCII presentation but
could also tune the peptide repertoire. In cell fractionation studies,
theMHC class II-like protein H2-O has been reported to concentrate
more with the EE fraction as compared to the LE fraction, while the
peptide-loading chaperone H2-M shows the opposite trend
(Gondré-Lewis et al., 2001). While H2-O has been characterised
as having an inhibitory effect on H2-M, it has also been shown
to modulate the repertoire of peptides presented on MHCII
via unclear mechanisms (Denzin et al., 2005; Karlsson, 2005).
Owing to lack of working antibodies for mouse cells, we were not
able to analyse H2-O in our system. Nevertheless, H2-O has
been shown to dissociate from H2-M at an acidic pH, thereby
releasing the inhibition of peptide loading by H2-M (Jiang et al.,
2015). This mechanism would allow peptide loading even in the
presence of H2-O. Different ratios of H2-M and H2-O could thus
distinguish the peptides sent out from eMIICs from those
originating from mature MIICs.
By using TEM, we found antigen in vesicles with diverse
morphologies (Fig. 1F, left; Fig. S1A). Various compartments,
ranging from spherical to multilobular, harboured intralumenal
vesicles, consistent with reports characterising MIICs with
multivesicular features (Roche and Furuta, 2015; Unanue et al.,
2016; van Lith et al., 2001; Xiu et al., 2011). Antigen-containing
single-membrane vesicles with round or horse-shoe shapes were
also detected. While it has been shown in dendritic cells that
intralumenal vesicles are not required for MHCII loading (Bosch
et al., 2013), multilamellar MIICs have also been reported
(Unanue et al., 2016). These notions suggest that MIIC function
is not bound to a certain vesicle morphology. Based on both the
morphological and vesicle marker-based heterogeneity, we
propose that early peripheral antigen vesicles, eMIICs, are
functional MIICs that are in transit (Fig. 6). While eMIICs
might part off and fuse again or migrate as such to the perinuclear
region for gradual maturation into MIICs, we suggest that they are
functional throughout the pathway.
MATERIALS AND METHODS
For more information about reagents and antibodies, please see Table S1.
Cells and mice
A20 mouse lymphoma cells stably expressing a hen egg lysozyme (HEL)-
specific IgM BCR (D1.3) (Williams et al., 1994) and 1E5T cells, kind gifts
from Prof Facundo Batista (the Ragon Institute of MGH, MIT and Harvard,
USA), stably expressing a transgenic TCR specific for HEL108–116/I-Ad
(Adorini et al., 1993) were maintained in complete RPMI [cRPMI; RPMI
1640 with 2.05 mM L-glutamine supplemented with 10% fetal calf serum
(FCS), 50 μM β-mercaptoethanol, 4 mM L-glutamine, 10 mM HEPES and
100 U/ml penicillin/streptomycin]. Cells were regularly examined for
bacterial and fungal contaminations and tested for mycoplasma
contaminations, but no other tests were run on the cell lines. Primary
splenic B cells were isolated from 2–5-month-old male and femaleMD4mice
[C57BL/6-Tg(IghelMD4)4Ccg/J, The Jackson Laboratory] using a negative
selection kit (StemCell Technologies, #19854). All animal experiments were
approved by the Ethical Committee for Animal Experimentation in Finland,
and were performed in adherencewith the rules and regulations of the Finnish
Act on Animal Experimentation (62/2006) and according to the 3R-principle
(animal license numbers: 7574/04.10.07/2014, KEK/2018-2504-Mattila,
10727/2018).
Transfection
A20 D1.3 cells were transfected as previously described (Šuštar et al.,
2018). Briefly, 2×106 cells were resuspended in 180 µl of 2S transfection
buffer (5 mM KCl, 15 mM MgCl2, 15 mM HEPES, 50 mM sodium
succinate, 180 mMNa2HPO4/ NaH2PO4 pH 7.2) containing 2 µg of plasmid
and electroporated using an AMAXA electroporation machine (program
X-005, Biosystem) in 0.2 cm gap electroporation cuvettes. Cells were then
transferred to 2 ml of cRPMI to recover overnight. Rab5a–GFP plasmid was
a kind gift from Prof. Johanna Ivaska (Turku Bioscience, University of
Turku and Åbo Akademi University, Turku, Finland.).
Fig. 6. Model of antigen processing in B cells. B cells internalise antigen and surface MHCII (sMHCII) and target them to early MHCII compartments (eMIIC) to
support fast antigen processing and pMHCII presentation. At later stages, antigen is targeted to classical MIIC compartments in the perinuclear region
for further pMHCII presentation.
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B cell activation and visualisation of antigen vesicles by
immunofluorescence
A20 D1.3 or isolated primary B cells were activated with 10 µg/ml of Alexa
Fluor 647- or Rhodamine Red-X (RRx)-conjugated anti-mouse-IgM
antibody (Jackson ImmunoResearch), unless indicated otherwise. Cells
were labelled with fluorescently labelled anti-IgM for 10 min on ice, washed
with PBS to remove excess unbound antigen and resuspended in imaging
buffer (PBS, 10% FCS). When indicated, cells were also labelled with anti-
MHCII conjugated to Alexa Fluor 488 on ice. After washing, cells were
activated for different time points in an incubator (5% CO2, 37°C) in a 12-
wells PTFE diagnostic slide (Thermo Fisher Scientific, #10028210), coated
with fibronectin, and fixed with 4% PFA 10 min at room temperature.
Samples were blocked and permeabilised with blocking buffer (5% horse or
donkey serum, 0.3% Triton X-100 in PBS) for 20 min at room temperature.
After blocking, samples were stained with primary antibodies for 1 h at
room temperature or 4°C overnight in staining buffer (1% BSA, 0.3% Triton
X-100 in PBS), followed by washes with PBS and incubation with the
secondary antibodies for 30 min at room temperature in PBS. Samples were
mounted using FluoroMount-G containing DAPI (Thermo Fisher
Scientific, #00495952).
Visualisation of antigen vesicles by live imaging
A20 D1.3 cells (1×106/ml) were labelled with 125 nM LysoTracker Deep
Red (Thermo Fisher Scientific, #L12492) for 1 h in an incubator (5% CO2,
37°C), washed with PBS and resuspended in cRPMI. Cells were then
labelled with 10 μg/ml of donkey anti-mouse-IgM antibody conjugated to
Alexa Fluor 488 on ice for 10 min and washed with cold PBS. For surface
MHCII internalisation experiments, cells were stained on ice with anti-
MHCII conjugated to Alexa Fluor 488 and 10 µl/ml donkey-anti mouse-
IgM conjugated to RRx for 5 min and washed with cold PBS. Cells were
resuspended in cold imaging buffer and seeded on four-well MatTek dishes
on ice. After seeding, cells were activated at 37°C inside the environmental
chamber of the microscope and image immediately.
Image acquisition and processing, spinning disk confocal
microscopy
Images were acquired using a 3i CSU-W1 spinning disk equipped with 405,
488, 561 and 640 nm laser lines and 510–540, 580–654 and 672–712 nm
filters and 63× Zeiss Plan-Apochromat objective. Hamamatsu sCMOS Orca
Flash4 v2 |C11440-22CU (2048×2048 pixels, 1×1 binning) was used to
image fixed samples unless otherwise indicated, and Photometrics Evolve
10 MHz Back Illuminated EMCCD (512×512 pixels, 1×1 binning) camera
was used to image live samples.
All SDCM images were deconvolved with Huygens Essential version
16.10 (Scientific Volume Imaging, The Netherlands, http://svi.nl), using the
CMLE algorithm, with a signal-to-noise ratio of 20 and 40 iterations. For
SRRF, 20–50 images were acquired from one single plane using time-lapse
mode and processed in Fiji ImageJ using the SRRF module.
Colocalisation analysis
Colocalisation analysis on spinning disk confocal microscope images was
performed with Huygens Essential version 16.10 (Scientific Volume
Imaging, The Netherlands, http://svi.nl), using optimised automatic
thresholding. Colocalisation on SRRF images was performed with ImageJ
using the Colocalisation Threshold tool. Graphs and statistics were prepared
with GraphPad Prism (GraphPad Software, La Jolla, CA).
Analysis of antigen clustering
Cluster analysis of the deconvolved data was performed by batch processing
in MATLAB R2018b (MathWorks). Binary masks were created from full
volumes containing one cell using the method by Otsu. Objects were then
segmented in 3D using the regionprops function. Only objects inside a
circular mask were kept in order to exclude clusters from adjacent cells, for
simplicity this was undertaken in 2D bymanually overlaying the image with
a circle. The MTOC channel was segmented in the same way and the cluster
with the highest intensity value was identified as MTOC. The distances of
each cluster to the MTOC was calculated from the centroid positions in 3D.
Graphs and statistics were prepared on GraphPad Prism. The scripts can be
found on MattilaLab’s GitHub (https://github.com/mattilalab/hernandez-
perez-et-al-2019).
Structured illumination microscopy
The samples were prepared as above in the ‘B cell activation and
visualisation of antigen vesicles by immunofluorescence’ section on
fibronectin-coated MatTek dishes and mounted in Vectashield (Vector
Laboratories) mounting medium. 3D structured illumination microscopy
(SIM) Imaging was performed with GE Healthcare, DeltaVision OMX SR
V4 with 60×/1.42 SIM Olympus Plan Apo N objective, front illuminated
sCMOS cameras, and 488, 568 and 640 nm solid-state lasers by optical
sectioning at 0.125 µm steps. The SIM reconstruction was performed with
OMX Acquisition software version 3.70. (GE Healthcare, UK).
Antigen internalisation for flow cytometry
A20 D1.3 cells were stained on ice for 10 min with anti-IgM conjugated to
biotin (Southern Biotech) or HEL–biotin and washed with PBS. Cells were
incubated at 37C and 5% CO2 at different time points. For time 0, the
samples were kept on ice all the time after incubation, and stained with
streptavidin-633 (LifeTechonologies #S-21375) for 20 min, before being
washed and analysed. BD LSR Fortessa analyser equipped with four lasers
(405, 488, 561 and 640 nm) was used. Data was analysed using FlowJo v10
(Tree Star).
Antigen internalisation and immunofluorescence
A20 D1.3 cells were stained on ice for 10 min with biotinylated anti-IgM
antibody conjugated to Alexa Fluor 647 (labelled in-house) and washed
with PBS. Cells were resuspended in Imaging Buffer (PBS, 10% FCS) and
activated for different time points in an incubator (5% CO2, 37°C) on
fibronectin-coated 12-well microscope slide. After activation, slides were
kept on ice to stop internalisation and stained with streptavidin–Alexa Fluor
488 (#S11223) for 10 min. Cells were washed with PBS and fixed with 4%
PFA 10 min at room temperature. Samples were mounted using
FluoroMount-G (Thermo Fisher Scientific, 00-4958-02).
DQ-Ova proteolysis reporter
DQ-Ovalbumin (Thermo Fisher Scientific, D12053) was biotinylated in-
house with EZ-Link Maleimide–PEG2–biotin (Thermo Fisher Scientific,
21901BID). HEL from (Sigma-Aldrich, #L6876) was biotinylated using
EZ-Link™ Sulfo-NHS-LC-LC-Biotin (Thermo Fisher Scientific, 21338).
A20 D1.3 cells were first incubated with 10 μg/ml biotin-HEL or
biotinylated anti-IgM (Southern Biotech) for 10 min on ice. After
washing with PBS, cells were incubated for 5 min on ice with unlabelled
streptavidin for immunofluorescence samples or Alexa Fluor 633-labelled
streptavidin for flow cytometry samples, washed with PBS, and incubated
5 min on ice with biotinylated DQ-Ova. After three washes with PBS, cells
were activated in an incubator (5% CO2, 37°C) to allow internalisation of
the probe-linked antigen. After the activation, cells were placed on ice and
analysed by flow cytometry immediately. For immunofluorescence
samples, cells were activated on 12-well slides coated with fibronectin in
the incubator, fixed with 4% PFA after activation, and stained as previously
described. DQ-Ova was excited with 488 nm laser and measured with filters
identical to Alexa Fluor 488 or GFP.
Assessment of low pH for flow cytometry
A20 D1.3 cells were stained on ice for 10 min with anti-IgM conjugated to
Alexa Fluor 647 (5 µg/ml) and FITC (5 µg/ml) and washed with PBS. Cells
were then incubated at 37°C and 5% CO2 at different time points in a 96-
well-plate for flow cytometry analysis. After incubation, cells were kept on
ice and analysed using a BD LSR Fortessa analyser equipped with four
lasers (405, 488, 561 and 640 nm). As time 0, the samples were kept on ice
all the time. Data was analysed using FlowJo v10 (Tree Star).
Transmission electron microscopy
A20 D1.3 cells were activated with a mixture of 6 nm colloidal-gold
conjugated goat anti-mouse IgM (Jackson ImmunoResearch, 115-195-075;
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1:650 dilution) and 20 µg/ml Alexa Fluor 647-labelled donkey anti-mouse
IgM F(ab′)2 fragments (Jackson ImmunoResearch, 715-606-020) in
imaging buffer (0.5 mM CaCl2, 0.2 mM MgCl2, 5.5 mM D-Glucose,
10% FBS in PBS) and placed on fibronectin (4 µg/ml)-coated glass
coverslips (thickness #1) for 15 or 75 min. The cells were fixed with 2%
glutaraldehyde (EM grade, Sigma-Aldirch, G7651) in 0.1 M sodium
cacodylate buffer, pH 7.4, for 30 min at room temperature, and then
washed twice for 3 min with 0.1 M sodium cacodylate buffer, pH 7.4. The
samples were processed for TEM as described in Jokitalo et al. (2001);
60-nm-thick sections parallel to the cover slip were cut using a Leica EM
Ultracut UC7 ultramicrome (Leica Mikrosysteme GmbH, Austria). The
electron micrographs were post stained with uranyl acetate and lead citrate,
and imaged with a Jeol JEM 1400 transmission electron microscope (Jeol
Ltd., Tokyo, Japan) equipped with a bottom mounted CCD camera (Orius
SC 1000B, Gatan Inc., Pleasanton, CA) and Jeol JEM-1400 Plus equipped
with an OSIS Quemesa bottom-mounted CCD camera (EMSIS, Germany),
both operating at 80 kV.
DAB endosome ablation
The endosome ablation assay was adapted from Pond andWatts (1999). A20
D1.3 cells (107/ml) were incubated in FCS-free RPMI for 45 min at 37°C.
Cells were surface-stained on ice with 10 µg/ml of anti-IgM conjugated to
biotin (Southern Biotech) for 10 min, followed by one PBS wash. Then, cells
were incubated with streptavidin–HRP for 10 min on ice and washed twice
with PBS. Internalisation of anti-IgM–HRP was initiated by incubation at
37°C and 5% CO2 for different times (10, 20 and 40 min). After that, vesicle
trafficking was stopped by incubation on ice and anti-IgM–HRP-containing
endosomes were ablated by addition of 0.1 mg/ml DAB (Santa Cruz
Biotechnology, sc-24982) and 0.025% H2O2 in freshly prepared DAB buffer
(70 mM NaCl, 20 mM HEPES, 2 mM CaCl2 and 50 mM ascorbic acid) for
30 min on ice in the dark. Ascorbic acid is a membrane-impermeable
molecule that acts as a radical scavenger inhibiting extracellular HRP activity
to avoid DAB deposits on the plasma membrane. As a control, cells were
incubated in DAB buffer with 0.1 mg/ml DAB, but without HRP or without
H2O2. Cells were then washed three times with PBS containing 1% BSA and
kept on ice. Viability after the endosome ablation, assessed by Trypan Blue
staining, was 95–98%.
Antigen presentation measured by ELISA
After endosome ablation, A20 D1.3 cells were incubated with 10 µg/ml of
HEL for 1 h at 37°C in cRPMI. After 1 h, cells were washed and resuspend
in cRPMI. A20 D1.3 B cells were mixed with 1E5T cells (ratio 2:1) and
incubated at 37°C and 5% CO2 overnight. IL-2 secretion levels were
measured the next day by ELISA on half-area 96-well plates coated with
capture antibodies (anti-IL-2) for 1 h at 37°C in 25 µl of PBS. Non-specific
binding sites were blocked overnight at 4°C in 150 µl of blocking buffer
(PBS, 1% BSA). Appropriate dilutions of 50 µl supernatant samples in
cRPMI were added to the ELISA plate for an 1–2 h incubation at 37°C.
Biotin-conjugated detection antibodies (anti-IL-2–biotin) in 50 µl of
blocking buffer were added for 1 h at room temperature followed by 50 µl
alkaline phosphatase (AP)–streptavidin in blocking buffer for 1 h at room
temperature. In between all incubation steps, plates werewashed with 150 µl
washing buffer (PBS with 0.05% Tween-20). The final wash was completed
with two washes with 150 µl of water. Finally, 50 µl of pNPP solution was
added and the optical density (OD) was measured at 405 nm. Typical time
for AP–substrate incubation before measurement was ∼10–20 min at room
temperature, before reaching signal saturation.
All ELISA samples were run in duplicates, and OD values were averaged
and blank background was subtracted. All samples were normalised to
values of the control cells (100%) and data is presented as mean±s.d. of three
experiments.
Statistical analysis and illustrations
Statistical significances were calculated using unpaired Student’s t-test
assuming normal distribution of the data. Statistical values are denoted as:
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Graphs were created in
GraphPad Prism 6 and illustrations were created with BioRender.
Figure formatting was undertaken on Inkscape v.092.2.
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Juséliuksen Säätiö) , the Jane and Aatos Erkko Foundation (Jane ja Aatos Erkon
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Gondré-Lewis, T. A., Moquin, A. E. and Drake, J. R. (2001). Prolonged antigen
persistence within nonterminal late endocytic compartments of antigen-specific B
lymphocytes. J. Immunol. 166, 6657-6664. doi:10.4049/jimmunol.166.11.6657
Gustafsson, N., Culley, S., Ashdown, G., Owen, D. M., Pereira, P. M. and
Henriques, R. (2016). Fast live-cell conventional fluorophore nanoscopy with
ImageJ through super-resolution radial fluctuations. Nat. Commun. 7, 12471.
doi:10.1038/ncomms12471
Henry, L. and Sheff, D. R. (2008). Rab8 regulates basolateral secretory, but not
recycling, traffic at the recycling endosome. Mol. Biol. Cell 19, 1815-2348. doi:10.
1091/mbc.e07-09-0902
Huotari, J. and Helenius, A. (2011). Endosome maturation. EMBO J. 30,
3481-3500. doi:10.1038/emboj.2011.286
Hutagalung, A. H. and Novick, P. J. (2011). Role of Rab GTPases in membrane
traffic and cell physiology.Physiol. Rev. 91, 119-149. doi:10.1152/physrev.00059.
2009
Jiang, W., Strohman, M. J., Somasundaram, S., Ayyangar, S., Hou, T., Wang, N.
and Mellins, E. D. (2015). pH-susceptibility of HLA-DO tunes DO/DM ratios to
regulate HLA-DM catalytic activity. Sci. Rep. 5, 17333. doi:10.1038/srep17333
Jokitalo, E., Cabrera-Poch, N., Warren, G. and Shima, D.T. (2001). Golgi clusters
and vesicles mediate mitotic inheritance independently of the endoplasmic
reticulum. J. Cell Biol. 154, 317-330. doi:10.1083/jcb.200104073
Karlsson, L. (2005). DM and DO shape the repertoire of peptide-MHC-class-II
complexes. Curr. Opin. Immunol. 17, 65-70. doi:10.1016/j.coi.2004.11.003
Kirkham,M., Fujita, A., Chadda, R., Nixon, S. J., Kurzchalia, T. V., Sharma, D. K.,
Pagano, R. E., Hancock, J. F., Mayor, S. and Parton, R. G. (2005).
Ultrastructural identification of uncoated caveolin-independent early endocytic
vehicles. J. Cell Biol. 168, 465-476. doi:10.1083/jcb.200407078
Lankar, D., Vincent-Schneider, H., Briken, V., Yokozeki, T., Raposo, G. and
Bonnerot, C. (2002). Dynamics of major histocompatibility complex class II
compartments during B cell receptor-mediated cell activation. J. Exp. Med. 195,
461-472. doi:10.1084/jem.20011543
Manders, E. M. M., Verbeek, F. J. and Aten, J. A. (1993). Measurement of co-
localization of objects in dual-colour confocal images. J. Microsc. 169, 375-382.
doi:10.1111/j.1365-2818.1993.tb03313.x
Martinez-Martin, N., Maldonado, P., Gasparrini, F., Frederico, B., Aggarwal, S.,
Gaya, M., Tsui, C., Burbage, M., Keppler, S. J., Montaner, B. et al. (2017). A
switch from canonical to noncanonical autophagy shapes B cell responses.
Science 355, 641-647. doi:10.1126/science.aal3908
Mellins, E. D. and Stern, L. J. (2014). HLA-DM and HLA-DO, key regulators of
MHC-II processing and presentation. Curr. Opin. Immunol. 26, 115-122. doi:10.
1016/j.coi.2013.11.005
Oksvold, M. P., Pedersen, N. M., Forfang, L. and Smeland, E. B. (2012). Effect of
cycloheximide on epidermal growth factor receptor trafficking and signaling. FEBS
Lett. 586, 3575-3581. doi:10.1016/j.febslet.2012.08.022
Pond, L. and Watts, C. (1999). Functional early endosomes are required for
maturation of major histocompatibility complex class II molecules in human B
lymphoblastoid cells. J. Biol. Chem. 274, 18049-18054. doi:10.1074/jbc.274.25.
18049
Rink, J., Ghigo, E., Kalaidzidis, Y. and Zerial, M. (2005). Rab conversion as a
mechanism of progression from early to late endosomes. Cell 122, 735-749.
doi:10.1016/j.cell.2005.06.043
Roche, P. A. and Furuta, K. (2015). The ins and outs of MHC class II-mediated
antigen processing and presentation. Nat. Rev. Immunol. 15, 203-216. doi:10.
1038/nri3818
Siemasko, K., Eisfelder, B. J., Williamson, E., Kabak, S. and Clark, M. R. (1998).
Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class
II containing late endosomes. J. Immunol. 160, 5203-5208.
Stoorvogel, W., Oorschot, V. and Geuze, H. J. (1996). A novel class of clathrin-
coated vesicles budding from endosomes. J. Cell Biol. 132, 21-33. doi:10.1083/
jcb.132.1.21
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Guermonprez, P. and Lennon-Duménil, A.-M. (2007b). Antigen presentation
by B lymphocytes: how receptor signaling directs membrane trafficking. Curr.
Opin. Immunol. 19, 93-98. doi:10.1016/j.coi.2006.11.011
Vonderheit, A. and Helenius, A. (2005). Rab7 associates with early endosomes to
mediate sorting and transport of Semliki forest virus to late endosomes.PLoS Biol.
3, e233. doi:10.1371/journal.pbio.0030233
Wandinger-Ness, A. and Zerial, M. (2014). Rab proteins and the
compartmentalization of the endosomal system. Cold Spring Harb. Perspect.
Biol. 6, a022616. doi:10.1101/cshperspect.a022616
West, M. A., Lucocq, J. M. and Watts, C. (1994). Antigen processing and class II
MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature
369, 147-151. doi:10.1038/369147a0
Whitmire, J. K., Asano, M. S., Kaech, S. M., Sarkar, S., Hannum, L. G.,
Shlomchik, M. J. and Ahmed, R. (2009). Requirement of b cells for generating
CD4+ T cell memory. J. Immunol. 182, 1868-1876. doi:10.4049/jimmunol.
0802501
Williams, G.T., Peaker, C.J., Patel, K.J. and Neuberger, M.S (1994). The alpha/
beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell
antigen receptor but not for capping or for serine/threonine-kinase recruitment.
Proc. Natl. Acad. Sci. U.S.A. 91, 474-478. doi:10.1073/pnas.91.2.474
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